Industry News
Pharmaceutical Industry News
BeiGene CEO touts ‘strategic asset’ in flagship US site and a fix to stock delisting risk
BeiGene CEO touts 'strategic asset' in flagship US site and a fix to stock delisting risk aliu Thu, 04/28/2022 - 11:17
If Lilly’s Alzheimer’s prospect proves its merit, it’s ‘inconceivable’ CMS wouldn’t cover the med: exec
If Lilly's Alzheimer's prospect proves its merit, it's 'inconceivable' CMS wouldn't cover the med: exec fkansteiner Thu, 04/28/2022 - 11:13
Sanofi’s Dupixent puts on another stellar show, and it’s still ‘at the beginning’ of its journey: exec
Sanofi's Dupixent puts on another stellar show, and it's still 'at the beginning' of its journey: exec aliu Thu, 04/28/2022 - 10:46
Despite early doubts, Merck’s COVID antiviral beats sales expectations and drives big growth
Despite early doubts, Merck's COVID antiviral beats sales expectations and drives big growth kdunleavy Thu, 04/28/2022 - 10:44
WuXi Advanced Therapies teams with Singapore group on cell therapy production tech
WuXi Advanced Therapies teams with Singapore group on cell therapy production tech jkeenan Thu, 04/28/2022 - 09:14
BioMarin posts record quarterly sales as Voxzogo launch heats up
BioMarin posts record quarterly sales as Voxzogo launch heats up fkansteiner Thu, 04/28/2022 - 08:38
Moderna to name Montreal for new biomanufacturing facility: report
Moderna to name Montreal for new biomanufacturing facility: report jkeenan Thu, 04/28/2022 - 08:17
AstraZeneca’s Ultomiris scores its 3rd FDA approval, setting up market clash with argenx
AstraZeneca's Ultomiris scores its 3rd FDA approval, setting up market clash with argenx kdunleavy Thu, 04/28/2022 - 08:04
Bristol Myers bags FDA nod for blockbuster-to-be cardio drug Camzyos
Bristol Myers bags FDA nod for blockbuster-to-be cardio drug Camzyos fkansteiner Thu, 04/28/2022 - 07:27
Novartis rolls first Leqvio TV ads, focusing on resilient patients—and convenient dosing
Novartis rolls first Leqvio TV ads, focusing on resilient patients—and convenient dosing sharon.coey Thu, 04/28/2022 - 03:20
Lawmakers Dismiss McKinsey’s Apology on Opioid Crisis as ‘Empty’
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
Amgen vows to fight $7.1B tax bill tied to Puerto Rico manufacturing unit
Amgen vows to fight $7.1B tax bill tied to Puerto Rico manufacturing unit zbecker Wed, 04/27/2022 - 17:13
‘These lives matter’: Oxfam and partners urge J&J, Pfizer and Moderna investors to focus on vaccine equity efforts
'These lives matter': Oxfam and partners urge J&J, Pfizer and Moderna investors to focus on vaccine equity efforts zbecker Wed, 04/27/2022 - 15:37
Should You Use Probiotics for Vaginal Health?
Pills and suppositories that promise to balance the vaginal microbiome are lining drugstore shelves and online marketplaces. But are they backed by science?
Pfizer and Biohaven clinch migraine approval in Europe, beating AbbVie to key market
Pfizer and Biohaven clinch migraine approval in Europe, beating AbbVie to key market fkansteiner Wed, 04/27/2022 - 12:25
Merck’s C-suite shakeup logs another loss as marketing exec Garay leaves for Moderna
Merck's C-suite shakeup logs another loss as marketing exec Garay leaves for Moderna fkansteiner Wed, 04/27/2022 - 11:37
Johnson & Johnson follows Gilead with lawsuit targeting alleged HIV drug counterfeiters
Johnson & Johnson follows Gilead with lawsuit targeting alleged HIV drug counterfeiters kdunleavy Wed, 04/27/2022 - 11:03
GlaxoSmithKline’s sales soar thanks to Shingrix, COVID-19 antibody but oncology lags
GlaxoSmithKline's sales soar thanks to Shingrix, COVID-19 antibody but oncology lags aliu Wed, 04/27/2022 - 10:11
Novartis spotlights BeiGene-partnered cancer immunotherapy data to move it earlier in the treatment paradigm
Novartis spotlights BeiGene-partnered cancer immunotherapy data to move it earlier in the treatment paradigm kdunleavy Wed, 04/27/2022 - 09:06
AstraZeneca staves off last Tagrisso copycat with settlement—for now
AstraZeneca staves off last Tagrisso copycat with settlement—for now fkansteiner Tue, 04/26/2022 - 23:57